Compliance Rate
Compliance Rate
42.86%
Compliant submissions
3
Incompliant submissions
4
Total trials
7
My Organizations' Clinical Trials
Showing 1625 of 2008 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/22
End: 06/30/28
Due: 06/30/29
Phase: N/A
Priority: Normal
Start: 04/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/18/19
End: 05/06/24
Due: 05/06/25
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 01/01/28
Due: 01/01/29
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 07/18/19
End: 07/29/22
Due: 07/29/23
Phase: N/A
Priority: Normal
Start: 05/31/04
End: 12/04/15
Due: 12/04/16
Phase: N/A
Priority: Normal
Start: 05/05/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 10/31/09
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 10/18/21
End: 10/27/22
Due: 10/27/23
Phase: N/A
Priority: Normal
Start: 09/30/19
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 09/20/25
Due: 09/20/26
Phase: N/A
Priority: Normal
Start: 01/01/99
End: 05/31/99
Due: 05/31/00
Phase: N/A
Priority: Normal
Start: 09/03/19
End: 11/30/26
Due: 11/30/27
Phase: N/A
Priority: Normal
Start: 11/30/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/05/25
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 09/22/23
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 05/28/19
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 01/21/20
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 08/31/06
End: 01/31/08
Due: 01/31/09
Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4
Phase: N/A
Priority: Normal
Start: 03/07/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 05/15/21
End: 12/15/25
Due: 12/15/26
Phase: N/A
Priority: Normal
Start: 10/21/11
End: 02/07/22
Due: 02/07/23